H-GIL^GFVF^TL-OH

Ref. 3D-PP46625

Información del producto

• Nombre: H-GIL^GFVF^TL-OH
• Sinónimos: NH2-Gly-Ile-Leu^Gly-Phe-Val-Phe^Thr-Leu-OH

Descripción

Peptide H-GIL^GFVF^TL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GIL^GFVF^TL-OH include the following: Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes Y Tanaka, KD Amos, HG Joo - journal of cancer, 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.1508 Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes XH He, LH Xu, Y Liu - World Journal of Gastroenterology: WJG, 2005 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615439/ Sequence dependent conformational motion of a peptide in the HLA-A2 binding groove WS Meng , TK Gallaher - Protein and Peptide , 1996 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=4hzqbXzny7cC&oi=fnd&pg=PA51&dq=(%22H-GIL%5EGFVF%5ETL-OH%22+OR+%22NH2-Gly-Ile-Leu%5EGly-Phe-Val-Phe%5EThr-Leu-OH%22+OR+%22H-GILGFVFTL-OH%22+OR+%22GIL%5EGFVF%5ETL%22+OR+%22GILGFVFTL%22)+AND+peptide&ots=apCmiTpwTG&sig=mOzdGN6Lh2sEs7m6q8TjSZ2nYEI Rational design of peptide-based tumor vaccines WS Meng , LH Butterfield - Pharmaceutical research, 2002 - Springerhttps://link.springer.com/article/10.1023/A:1016497818471 Exploiting the Peptide-MHC Water Interface in the Computer-Aided Design of Non-Natural Peptides that Bind to the Class I MHC Molecule HLA-A2 WS Meng , HH Bui, IS Haworth - Molecular Simulation, 2000 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/08927020008022372 A model of water structure inside the HLA-A2 peptide binding groove. WS Meng , H von Grafenstein - International , 1997 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/9/9/1339/761015 The mechanistic basis of peptide-MHC binding and design of MHC-directed therapeutics WS Meng - 1998 - search.proquest.comhttps://search.proquest.com/openview/4e50691d9270fd629aa3e6ea0137cec2/1?pq-origsite=gscholar&cbl=18750&diss=y Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution WJ Storkus , HJ Zen III, RD Salter - Journal of , 1993 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/abstract/1993/08000/identification_of_t_cell_epitopes__rapid_isolation.3.aspx Development of Pro-Peptide Immunotherapy for Breast Cancer W Wei-Zan, WAYNE STATE UNIV DETROIT MI - 2000., 2000 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA385378 CHARACTERISATION OF MHC-PEPTIDE BINDING SPECIFICITIES BY STRUCTURAL STUDIES TOH XINYU - 2012 - core.ac.ukhttps://core.ac.uk/download/pdf/48655789.pdf Structure and dynamics of MHC class-I bound peptides SP Patil - 2008 - search.proquest.comhttps://search.proquest.com/openview/219708e423941b6eacfec8c7dcee7844/1?pq-origsite=gscholar&cbl=18750 Functional characterization of CTL against gp100 altered peptide ligands SO Dionne, MH Smith, FM Marincola - Cancer Immunology , 2003 - Springerhttps://link.springer.com/article/10.1007/s00262-002-0358-3 Towards chemically altered peptide ligands as T cell-targeted influenza vaccines SKR Huber, JJ Luimstra - for peptide , 2015 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2919352/download#page=106 Chemical modification of influenza CD8+ T-cell epitopes enhances their immunogenicity regardless of immunodominance SK Rosendahl Huber, JJ Luimstra, J van Beek - PloS one, 2016 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156462 Immune responses against conserved influenza epitopes: lessons for peptide S Rosendahl Huber - Scand J Immunol, 1997 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2919359/download Synthesis and biological activity of the prodrug of class I major histocompatibility peptide GILGFVFTL activated by beta-glucuronidase S Rawale, LM Hrihorczuk, Wei - Journal of medicinal , 2002 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm010352w Epitope Prediction Algorithms for Class I MHC Molecules RG Urban, RM Chicz, KC Parker - MHC Molecules: Expression, Assembly , 1996 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4684-6462-7_10 Fluorophore-assisted laser desorption/ionization-mass spectrometry (FALDI-MS) RE West III, EW Findsen, D Isailovic - International Journal of Mass , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1387380613002698 Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2-restricted T cell epitopes R Hoppes, R Oostvogels , JJ Luimstra - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/10/4803/97379 Whole inactvated influenza virus as an adjuvant for influenza peptide antigens PC Soema, SKR Huber, GJ Willems, JP Amorij - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2895100/download Formulation of influenza T cell peptides: in search of a universal influenza vaccine P Soema - 2015 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2895105/download Prediction and preliminary screening of HLA-A* 0201-restricted epitope peptides of human GPC 3 P Hu, Z Wei, R Li, D Wu, Z Meng - International Journal of , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/iji.12260 Molecular Modeling of the Class I Human Histocompatibility Molecule HLA-A2 Presenting an Allele-Specific Nonapeptide from Influenza Matrix Protein N Zimmermann, O Rötzschke , K Falk - Edition in English, 1992 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/anie.199208861 Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. M DiBrino, KC Parker, J Shiloach - Proceedings of the , 1993 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.90.4.1508 Competition among peptides in melanoma vaccines for binding to MHC molecules LW Thompson, CF Garbee, S Hibbitts - Journal of , 2004 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2004/11000/competition_among_peptides_in_melanoma_vaccines.2.aspx Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability KM Miles, JJ Miles , F Madura, AK Sewell , DK Cole - Molecular immunology, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589010006073 Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. KC Parker, MA Bednarek, JE Coligan - Journal of immunology , 1994 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/152/1/163/25918 Analysis of a naturally occurring HLA class I-restricted viral epitope. K Falk, O Rötzschke , S Stevanović, V Gnau - , 1994 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414868/ Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry JJ Miles , MP Tan, G Dolton - The Journal of , 2018 - Am Soc Clin Investighttps://www.jci.org/articles/view/91512 Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity F Micheletti, R Guerrini, A Formentin - European journal of , 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199908)29:08%3C2579::AID-IMMU2579%3E3.0.CO;2-E Structural and functional characterization of peptide-beta2m fused HLA-A2/MART127-35 complexes C Shen, CC Chang, J Zhang, W Guo, L Xia - Biochemical and , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X06001999 Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A* 0201-binding peptides from the Melan-A/MART A van Elsas , SH van der Burg - European journal of , 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830260803 Identification of B cell epitopes reactive to human papillomavirus type-16L1-derived peptides A Fukui, S Matsueda , K Kawano, N Tsuda, N Komatsu - Virology journal, 2012 - Springerhttps://link.springer.com/article/10.1186/1743-422X-9-199

• Marca: Biosynth